Invicorp injectable formulation of vasoactive intestinal polypeptide data

SNTKY announced results of a retrospective study of 269 patients treated with Invicorp or prostaglandin E1 (PGE1).

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE